Laboratoire des Fièvres Hémorragiques Virales, Cotonou, Benin.
Virology Department, Institut Pasteur CNR des fièvres hémorragiques virales (CNR FHV), Lyon, France.
Emerg Microbes Infect. 2020 Dec;9(1):1761-1770. doi: 10.1080/22221751.2020.1796528.
We report two outbreaks of Lassa fever that occurred in Benin in 2014 and 2016 with 20 confirmed cases and 50% (10/20) mortality. Benin was not previously considered to be an endemic country for Lassa fever, resulting in a delay to diagnose the disease and its human transmission. Molecular investigations showed the viral genomes to be similar to that of the Togo strain, which is genetically very different from other known strains and confirms the existence of a new lineage. Endemic circulation of Lassa virus in a new territory and the genetic diversity thus confirm that this virus represents a growing threat for West African people. Given the divergence of the Benin strain from the prototypic Josiah Sierra Leone strain frequently used to generate vaccine candidates, the efficacy of vaccine candidates should also be demonstrated with this strain.
我们报告了 2014 年和 2016 年贝宁发生的两起拉沙热疫情,共有 20 例确诊病例,死亡率为 50%(10/20)。贝宁以前不被认为是拉沙热流行国家,导致疾病的诊断和人际传播出现延误。分子调查显示,病毒基因组与多哥株相似,其在遗传上与其他已知株有很大不同,证实存在一个新谱系。拉沙病毒在新领土的流行循环和遗传多样性因此证实,这种病毒对西非人民构成日益严重的威胁。鉴于贝宁株与用于产生疫苗候选株的原型乔赛亚·塞拉利昂株存在差异,也应该用该株来证明候选疫苗的效力。